SB

Sarai Bronfeld

Partner at NFX

Tel Aviv-Yafo, Tel Aviv District

Overview

Work Experience

  • Board Member

    2024 - Current

  • Partner

    2024

  • Principal

    2022 - 2024

  • Associate

    2021 - 2022

    $450M pre-seed and seed only Venture Capital. SF\IL-based. ~$1B AUM.

  • Board Member

    2024

  • Business Consultant

    2021 - 2024

  • Investor

    2018 - 2021

    Late-stage and pre IPOs. $100M AUM.

  • Head Of Business Operations

    2019 - 2020

  • Business Operations

    2019 - 2020

  • CSO

    2018 - 2020

  • Research Scientist

    2017 - 2019

    Research focused on the endocrine and paracrine aspects of pancreatic cancer development and tumor metabolism. Master thesis on Klotho Gene, hormone that links longevity to cancer protection. Thesis Supervisor: Prof. Ido Wolf, Director of Oncology Department.

Relevant Websites